Clinical Trial Update: IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for IBP-9414 targeting prevention of necrotizing enterocolitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Necrotizing Enterocolitis

Drugs mentioned

• IBP-9414

Snippet

Sponsor: Infant Bacterial Therapeutics | Conditions: Necrotizing Enterocolitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING